The newly built centre will work as the state-of-the-art facility for not just ethical animal studies but spans from basic, applied to regulatory animal research.
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
This is the third major regulatory milestone for the vaccine candidate following acceptance of regulatory submissions in Europe and Japan
CGHS would give robust coverage to pensioners and with new innovations and practices
Japan’s Ministry of Health, Labour and Welfare (MHLW) has recently approved AstraZeneca's long-acting antibody combination “Evusheld” for the prevention ) and treatment of COVID-19.
On the precision oncology front, expanded larotrectinib data will focus on efficacy and safety findings for pediatric and adult patients with NTRK gene fusion-positive solid tumors
COVID-19 Vaccine (DS-5670) in Unvaccinated Individuals in Japan
It´s the first trial to demonstrate the benefits of dual pathway inhibition
WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Subscribe To Our Newsletter & Stay Updated
